Get started
Author

Nathaniel Oladoye Olatunji

Observed names: N. Olatunji, Olatunji Nathaniel Oladoye
ORCID: 0009-0006-4026-3384
Observed ORCID: 0009-0006-4026-3384
OpenAlex ID: A5116887491
QSAR-guided design, DFT, molecular docking, and ADMET prediction of novel thiazolidinone-based indole derivatives as potent α-glucosidase inhibitors
2026 · Augustine Onuche Sule, Mary Ikhaote Ohiole, et al. · Letters in Drug Design & Discovery
Phytochemical Screening: In-vitro, PASS, ADMET and Molecular Docking studies of Antifungal activities of Methanol Extract of Kigelia Africana Fruit Peels
2026 · Omodara Niyi Basil, Olatunde Abimbola Modupe, et al.
Leveraging on Computational Strategies to Alleviate Vaso-Occlusive Crises in Sickle Cell Disease
2026 · Yemisi Elizabeth Asibor, Abel Kolawole Oyebamiji, et al. · Journal of Pharmaceutical Innovation
2D QSAR model using multiple linear regression (MLR)-Genetic algorithm (GA) method for the predication of pKa of some imidazole derivatives
2025 · Pelumi Gabriel Adebayo, Nathaniel Oladoye Olatunji, et al. · International Journal of Chemical Studies
PDF
Molecular modeling and pharmacokinetics studies of sulfamidophosphonate derivatives as potential candidate against Staphylococcus aureus
2025 · Abimbola Modupe Olatunde, Kehinde Gabriel Obiyenwa, et al. · Eclética Química
PDF
In silico appraisal of inhibitory activity of 1,2,4-triazolo[4,3-a]pyrazine derivatives against resistant malarial parasite (Plasmodium falciparum) via DFT, molecular docking, and ADMET approaches
2024 · S/ Banjo, N. Olatunji, et al. · Биофармацевтический журнал
Works count: 6
Citation count:
H-index:
I10-index:
Year
Topic
Type